Lee Ming-Jen, Su Yi-Ning, You Huey-Ling, Chiou Shinn-Chong, Lin Li-Chu, Yang Chih-Chao, Lee Wang-Chao, Hwu Wu-Liang, Hsieh Fon-Jou, Stephenson Dennis A, Yu Chia-Li
Department of Medical Genetics, National Taiwan University School of Medicine, Taipei, Taiwan.
Hum Mutat. 2006 Aug;27(8):832. doi: 10.1002/humu.9446.
Neurofibromatosis type 1 (NF1), characterized by skin neurofibromas and an excess of café-au-lait spots, is due to mutations in the neurofibromin (NF1) gene. Identifying the genetic defect in individuals with the disease represents a significant challenge because the gene is extremely large with a high incidence of sporadic mutations across the entire gene ranging from single nucleotide substitutes to large deletions. In the present study, we have used a combination of techniques (heteroduplex analysis, sequencing, loss of heterozygosity and quantification of gene dosage) to define the genetic defect in 68 individuals from a cohort of 107 NF1 Taiwanese patients of Chinese origin. Fifty-eight were initially identified using heteroduplex analytical techniques and confirmed by sequence analysis. A further five were identified by direct sequence analysis alone. The reminders were shown to carry large deletions in the NF1 gene by demonstrating loss of heterozygosity that was confirmed by gene dosage measurements using quantitative-PCR techniques. Mis-sense, non-sense, frame-shift or splice-site mutations were identified across the entire gene of which the majority (45/68) were novel in nature. The detection rate with the various analytical techniques and the types of mutation detected are consistent with published data involving both individuals and large cohort studies from other ethnic backgrounds.
1型神经纤维瘤病(NF1)以皮肤神经纤维瘤和大量咖啡斑为特征,由神经纤维瘤蛋白(NF1)基因突变引起。确定患有该疾病个体的基因缺陷是一项重大挑战,因为该基因非常大,整个基因中散发性突变的发生率很高,范围从单核苷酸替代到大片段缺失。在本研究中,我们使用了多种技术(异源双链分析、测序、杂合性缺失和基因剂量定量)来确定来自107名中国台湾NF1患者队列中的68名个体的基因缺陷。最初使用异源双链分析技术鉴定出58例,并通过序列分析得到证实。另外5例仅通过直接序列分析鉴定。其余病例通过显示杂合性缺失表明在NF1基因中携带大片段缺失,这通过使用定量PCR技术的基因剂量测量得到证实。在整个基因中鉴定出错义、无义、移码或剪接位点突变,其中大多数(45/68)是新发现的。各种分析技术的检测率和检测到的突变类型与涉及其他种族背景个体和大型队列研究的已发表数据一致。